Abstract
Sphingomyelin synthase 1 (SMS1) is a vitally important enzyme responsible for the synthesis of sphingomyelin and diacylglycerol from phosphatidylcholine and ceramide in eukaryotic cells. Previously, we have investigated the structure of the human gene SGMS1 in detail and identified a lot of its transcripts. We have found mRNA isoforms that differ in their 5′-untranslated regions (UTRs) and encode a full-length protein. We have also detected the transcripts that arise from an alternative exon combination and comprise a coding region of the gene and a 3′-UTR. Computer analysis revealed that the synthesis of the transcripts differing in 5′-UTRs starts from different SGMS1 gene promoters. In the present study performed using the realtime PCR, we demonstrated that the contents of five alternative gene transcripts that differ in their 5′-UTRs is substantially dissimilar in the studied human tissues. The transcripts synthesized under the control of the distal promoter comprising exon 1 were the most abundant. The content of the transcripts comprising 5′-terminal exons, the synthesis of which is enabled by the promoters localized in the gene introns, is lower. Different contents of gene SGMS1 transcripts that differ in 5′-UTRs indicates that the use of certain alternative promoters is tissue-specific and, apparently, strictly regulated. The 5′-UTR structures of the SGMS1 gene transcripts controlled by alternative promoters differ significantly, which indicates that the gene functioning is regulated at the posttranscriptional level.
Similar content being viewed by others
References
Tress M.L., Martelli P.L., Frankish A., Reeves G.A., Wesselink J.J., Yeats C., Óason P.L’., Albrecht M., Hegyi H., Giorgetti A., Raimondo D., Lagarde J., Laskowski R.A., López G., Sadowski M.I., Watson J.D., Fariselli P., Rossi I., Nagy A., Kai W., Størling Z., Orsini M., Assenov Y., Blankenburg H., Huthmacher C., Ramírez F., Schlicker A., Denoeud F., Jones P., Kerrien S., Orchard S., Antonarakis S.E., Reymond A., Birney E., Brunak S., Casadio R., Guigo R., Harrow J., Hermjakob H., Jones D.T., Lengauer T., A. Orengo C., Patthy L., Thornton J.M., Tramontano A., Valencia A. 2007. The implications of alternative splicing in the ENCODE protein complement. Proc. Natl. Acad. Sci. U. S. A. 104, 5495–5500.
Lee J.Y., Yeh I., Park J.Y., Tian B. 2007. PolyA-DB 2: mRNA polyadenylation sites in vertebrate genes. Nucleic Acids Res. 35, D165–D168.
Denoeud F., Kapranov P., Ucla C., Frankish A., Castelo R., Drenkow J., Lagarde J., Alioto T., Manzano C., Chrast J., Dike S., Wyss C., Henrichsen C.N., Holroyd N., Dickson M.C., Taylor R., Hance Z., Foissac S., Myers R.M., Rogers J., Hubbard T., Harrow J., Guigó R., Gingeras T.R., Antonarakis S.E., Reymond A. 2007. Prominent use of distal 5′ transcription start sites and discovery of a large number of additional exons in ENCODE regions. Genome Res. 17, 746–759.
Kimura K., Wakamatsu A., Suzuki Y., Ota T., Nishikawa T., Yamashita R., Yamamoto J.-I., Sekine M., Tsuritani K., Wakaguri H., Ishii S., Sugiyama T., Saito K., Isono Y., Irie R., Kushida N., Yoneyama T., Otsuka R., Kanda K., Yokoi T., Kondo H., Wagatsuma M., Murakawa K., Ishida S., Ishibashi T., Takahashi-Fujii A., Tanase T., Nagai K., Kikuchi H., Nakai K., Isogai T., Sugano S. 2006. Diversification of transcriptional modulation: Large-scale identification and characterization of putative alternative promoters of human genes. Genome Res. 16, 55–65.
Dergunova L.V., Vladychenskaia I.P., Polukarova L.G., Raevskaia N.M., Lelikova G.P., Limborskaia S.A. 1998. Features of the structure, expression and chromosomal mapping of the nucleotide sequences of Hmob3 and Hmob33, obtained from a human medulla oblongata cDNA library. Mol. Biol. (Moscow). 32, 249–254.
Dergunova L.V., Raevskaya N.M., Vladychenskaya I.P., Limborska S.A. 2003. Structural and functional analyses of the Hfb1, Hmob3, and Hmob33 cDNAs as an example of human brain-specific gene studies. Mol. Biol. (Moscow.) 37, 273–280.
Vladychenskaya I.P., Dergunova L.V., Dmitrieva V.G., Limborska S.A. 2004. Human gene MOB: Structure specification and aspects of transcriptional activity. Gene. 338, 257–265.
Vladychenskaya I.P., Dergunova L.V., Limborska S.A. 2002. In vitro and in silico analysis of the predicted human MOB gene encoding a phylogenetically conserved transmembrane protein. Biomol. Eng. 18, 263–268.
Huitema K., Van Den Dikkenberg J., Brouwers J.F.H.M., Holthuis J.C.M. 2004. Identification of a family of animal sphingomyelin synthases. EMBO J. 23, 33–44.
Yamaoka S., Miyaji M., Kitano T., Umehara H., Okazaki T. 2004. Expression cloning of a human cDNA restoring sphingomyelin synthesis and cell growth in sphingomyelin synthase-defective lymphoid cells. J. Biol. Chem. 279, 18688–18693.
Barceló-Coblijn G., Martin M.L., De Almeida R.F.M., Noguera-Salvà M.A., Marcilla-Etxenike A., Guardiola-Serrano F., Lüth A., Kleuser B., Halver J.E., Escribá P.V. 2011. Sphingomyelin and sphingomyelin synthase (SMS) in the malignant transformation of glioma cells and in 2-hydroxyoleic acid therapy. Proc. Natl. Acad. Sci. U. S. A. 108, 19569–19574.
Shakor A.B.A., Taniguchi M., Kitatani K., Hashimoto M., Asano S., Hayashi A., Nomura K., Bielawski J., Bielawska A., Watanabe K., Kobayashi T., Igarashi Y., Umehara H., Takeya H., Okazaki T. 2011. Sphingomyelin synthase 1-generated sphingomyelin plays an important role in transferrin trafficking and cell proliferation. J. Biol. Chem. 286, 36053–36062.
Subathra M., Qureshi A., Luberto C. 2011. Sphingomyelin synthases regulate protein trafficking and secretion. PLoS ONE. 6, e23644.
Yan N., Ding T., Dong J., Li Y., Wu M. 2011. Sphingomyelin synthase overexpression increases cholesterol accumulation and decreases cholesterol secretion in liver cells. Lipids Health Dis. 10, 46.
Rozhkova A.V., Dmitrieva V.G., Zhapparova O.N., Sudarkina O.Y., Nadezhdina E.S., Limborska S.A., Dergunova L.V. 2011. Human sphingomyelin synthase 1 gene (SMS1): Organization, multiple mRNA splice variants and expression in adult tissues. Gene. 481, 65–75.
Dergunova L., Rozhkova A., Sudarkina O., Limborska S. 2013. The use of alternative polyadenylation in the tissue-specific regulation of human SMS1 gene expression. Mol. Biol. Rep. 40, 6685–6690.
Sambrook J., Fritsch E.F., Maniatis T. 1989. Molecular Cloning: A Laboratory Manual. Cold Spring Harbor, NY: Cold Spring Harbor Lab. Press.
Chomczynski P. 1992. One-hour downward alkaline capillary transfer for blotting of DNA and RNA. Anal. Biochem. 201, 134–139.
Kaminska B., Filipkowski R.K., Zurkowska G., Lason W., Przewlocki R., Kaczmarek L. 1994. Dynamic changes in the composition of the AP-1 transcription factor DNA-binding activity in rat brain following kainateinduced seizures and cell death. Eur. J. Neurosci. 6, 1558–1566.
Pfaffl M.W., Horgan G.W., Dempfle L. 2002. Relative expression software tool (REST.) for group-wise comparison and statistical analysis of relative expression results in real-time PCR. Nucleic Acids Res. 30, e36.
Takai D., Jones P.A. 2002. Comprehensive analysis of CpG islands in human chromosomes 21 and 22. Proc. Natl. Acad. Sci. U. S. A. 99, 3740–3745.
Zuker M. 2003. Mfold web server for nucleic acid folding and hybridization prediction. Nucleic Acids Res. 31, 3406–3415.
Jacox E., Gotea V., Ovcharenko I., Elnitski L. 2010. Tissue-specific and ubiquitous expression patterns from alternative promoters of human genes. PLoS ONE. 5, e12274.
Chen J., Randeva H.S. 2010. Genomic organization and regulation of the human orexin (hypocretin) receptor 2 gene: Identification of alternative promoters. Biochem. J. 427, 377–390.
Longo A., Librizzi M., Naselli F., Caradonna F., Tobiasch E., Luparello C. 2013. PTHrP in differentiating human mesenchymal stem cells: Transcript isoform expression, promoter methylation, and protein accumulation. Biochimie. 95, 1888–1896.
Guske K., Schmitz B., Schelleckes M., Duning K., Kremerskothen J., Pavenstädt H., Brand S.-M., Brand E. 2014. Tissue-specific differences in the regulation of KIBRA gene expression involve transcription factor TCF7L2 and a complex alternative promoter system. J. Mol. Med. (Berlin). 92, 185–196.
Hoivik E.A., Witsoe S.L., Bergheim I.R., Xu Y., Jakobsson I., Tengholm A., Doskeland S.O., Bakke M. 2013. DNA methylation of alternative promoters directs tissue specific expression of Epac2 isoforms. PLoS ONE. 8, e67925.
Hertel J., Hirche C., Wissmann C., Ebert M., Höcker M. 2014. Transcription of the vascular endothelial growth factor receptor-3 (VEGFR3) gene is regulated by the zinc finger proteins Sp1 and Sp3 and is under epigenetic control. Cell Oncol. (Dordrecht). 37, 131–145.
Jiang Z., Qian L., Zou H., Jia Y., Ni Y., Yang X., Jiang Z., Zhao R. 2014. Porcine glucocorticoid receptor (NR3C1) gene: Tissue-specificity of transcriptional strength and glucocorticoid responsiveness of alternative promoters. J. Steroid Biochem. Mol. Biol. 141, 87–93.
Kudla G., Murray A.W., Tollervey D., Plotkin J.B. 2009. Coding-sequence determinants of gene expression in Escherichia coli. Science. 324, 255–258.
Davuluri R.V., Suzuki Y., Sugano S., Zhang M.Q. 2000. CART classification of human 5′ UTR sequences. Genome Res. 10, 1807–1816.
Wang L., Wessler S.R. 2001. Role of mRNA Secondary structure in translational repression of the maize transcriptional activator Lc(1,2). Plant Physiol. 125, 1380–1387.
Kozak M. 1991. Structural features in eukaryotic mRNAs that modulate the initiation of translation. J. Biol. Chem. 266, 19867–19870.
Author information
Authors and Affiliations
Corresponding author
Additional information
Original Russian Text © A.V. Rozhkova, I.B. Filippenkov, O.Yu. Sudarkina, S.A. Limborska, L.V. Dergunova, 2015, published in Molekulyarnaya Biologiya, 2015, Vol. 49, No. 2, pp. 325–333.
These authors contributed equally to the study.
Rights and permissions
About this article
Cite this article
Rozhkova, A.V., Filippenkov, I.B., Sudarkina, O.Y. et al. Alternative promoters located in SGMS1 gene introns participate in regulation of its expression in human tissues. Mol Biol 49, 287–294 (2015). https://doi.org/10.1134/S002689331501015X
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1134/S002689331501015X